Gaoqian Feng

Gaoqian Feng

Auto-generated profile, based on publicly available information

Gaoqian Feng

Nanjing Medical University

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2016 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
JBJames G. Beeson
James G. Beeson
DDDamien R Drew
Damien R Drew
MBMichelle J Boyle
Michelle J Boyle
GFGaoqian Feng
Gaoqian Feng
FFFreya J I Fowkes
Freya J I Fowkes
JRJack S Richards
Jack S Richards
Malaria accounts for an enormous burden of disease globally, with Plasmodium falciparum accounting for the majority of malaria, and P. vivax being a second important cause, especially in Asia, the Americas and the Pacific. During infection with Plasmodium spp., the merozoite form of the parasite invades red blood cells and replicates inside them. It is during the blood-stage of infection that malaria disease occurs and, therefore, understanding merozoite invasion, host immune responses to merozoite surface antigens, and targeting merozoite surface proteins and invasion ligands by novel vaccines and therapeutics have been important areas of research. Merozoite invasion involves multiple interactions and events, and substantial processing of merozoite surface proteins occurs before, during and after invasion. The merozoite surface is highly complex, presenting a multitude of antigens to the immune system. This complexity has proved challenging to our efforts to understand merozoite invasion and malaria immunity, and to developing merozoite antigens as malaria vaccines. In recent years, there has been major progress in this field, and several merozoite surface proteins show strong potential as malaria vaccines. Our current knowledge on this topic is reviewed, highlighting recent advances and research priorities.

1 March 2015 in Immunity
Verified
Journal Article
Open access
MBMichelle J. Boyle
Michelle J. Boyle
LRLinda Reiling
Linda Reiling
GFGaoqian Feng
Gaoqian Feng
CLChristine Langer
Christine Langer
FOFaith H. Osier
Faith H. Osier
JBJames G. Beeson
James G. Beeson
Antibodies play major roles in immunity to malaria; however, a limited understanding of mechanisms mediating protection is a major barrier to vaccine development. We have demonstrated that acquired human anti-malarial antibodies promote complement deposition on the merozoite to mediate inhibition of erythrocyte invasion through C1q fixation and activation of the classical complement pathway. Antibody-mediated complement-dependent (Ab-C') inhibition was the predominant invasion-inhibitory activity of human antibodies; most antibodies were non-inhibitory without complement. Inhibitory activity was mediated predominately via C1q fixation, and merozoite surface proteins 1 and 2 were identified as major targets. Complement fixation by antibodies was very strongly associated with protection from both clinical malaria and high-density parasitemia in a prospective longitudinal study of children. Ab-C' inhibitory activity could be induced by human immunization with a candidate merozoite surface-protein vaccine. Our findings demonstrate that human anti-malarial antibodies have evolved to function by fixing complement for potent invasion-inhibitory activity and protective immunity.

1 July 2014 in BMC Medicine
Verified
Journal Article
Open access
PDF file
FOFaith Ha Osier
Faith Ha Osier
GFGaoqian Feng
Gaoqian Feng
MBMichelle J Boyle
Michelle J Boyle
CLChristine Langer
Christine Langer
JZJingling Zhou
Jingling Zhou
JBJames G. Beeson
James G. Beeson
An understanding of the mechanisms mediating protective immunity against malaria in humans is currently lacking, but critically important to advance the development of highly efficacious vaccines. Antibodies play a key role in acquired immunity, but the functional basis for their protective effect remains unclear. Furthermore, there is a strong need for immune correlates of protection against malaria to guide vaccine development.

9 January 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JBJames G. Beeson
James G. Beeson
LKLiriye Kurtovic
Liriye Kurtovic
CDCarlota Dobaño
Carlota Dobaño
DOD. Herbert Opi
D. Herbert Opi
JCJo-Anne Chan
Jo-Anne Chan
MBMichelle J. Boyle
Michelle J. Boyle
Although there has been major recent progress in malaria vaccine development, substantial challenges remain for achieving highly efficacious and durable vaccines against Plasmodium falciparum and Plasmodium vivax malaria. Greater knowledge of mechanisms and key targets of immunity are needed to accomplish this goal, together with new strategies for generating potent, long-lasting, functional immunity against multiple antigens. Implementation considerations in endemic areas will ultimately affect vaccine effectiveness, so innovations to simplify and enhance delivery are also needed. Whereas challenges remain, recent exciting progress and emerging knowledge promise hope for the future of malaria vaccines.

6 September 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
MBM. J. Boyle
M. J. Boyle
JCJ. A. Chan
J. A. Chan
IHI. Handayuni
I. Handayuni
LRL. Reiling
L. Reiling
GFG. Feng
G. Feng
JBJames G. Beeson
James G. Beeson
Most studies on human immunity to malaria have focused on the roles of immunoglobulin G (IgG), whereas the roles of IgM remain undefined. Analyzing multiple human cohorts to assess the dynamics of malaria-specific IgM during experimentally induced and naturally acquired malaria, we identified IgM activity against blood-stage parasites. We found that merozoite-specific IgM appears rapidly in Plasmodium falciparum infection and is prominent during malaria in children and adults with lifetime exposure, together with IgG. Unexpectedly, IgM persisted for extended periods of time; we found no difference in decay of merozoite-specific IgM over time compared to that of IgG. IgM blocked merozoite invasion of red blood cells in a complement-dependent manner. IgM was also associated with significantly reduced risk of clinical malaria in a longitudinal cohort of children. These findings suggest that merozoite-specific IgM is an important functional and long-lived antibody response targeting blood-stage malaria parasites that contributes to malaria immunity.

1 November 2016 in Trends in Parasitology
Verified
Journal Article
Closed access
ATAndrew Teo
Andrew Teo
GFGaoqian Feng
Gaoqian Feng
GBGraham V. Brown
Graham V. Brown
JBJames G. Beeson
James G. Beeson
SRStephen J Rogerson
Stephen J Rogerson